Inhibition of interleukin 6, a new therapeutic option in rheumatoid arthritis Ricardo Blanco Alonso, Mario Agudo Bilbao

Protein-kinase Inhibitors: A New Treatment Pathway for Autoimmune and Inflammatory Diseases? Diana Hernández-Flórez, Lara Valor

Therapeutic options for the management of severe COVID-19: A rheumatology perspective Claudia Mendoza-Pinto, Mario García-Carrasco, Pamela Munguía Realpozo, Socorro Méndez-Martínez